Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The British Journal of Surgery|August 1, 1997
Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project GroupK M Tveit, I Guldvog, S Hagen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Changing aspects in the treatment of squamous cell carcinoma of the oral tongueH Vermund, A B Jacobsen, O Kaalhus, et al.
International Journal of Circumpolar Health|October 27, 2017
Treatment of acute myocardial infarction in the sub-arctic region of Norway. Do we offer an equal quality of care?J Norum, A Hovland, L Balteskard, et al.
Ecology and Evolution|June 27, 2014
Spatial and temporal genetic structure of a river-resident Atlantic salmon (Salmo salar) after millennia of isolationOdd Terje Sandlund, Sten Karlsson, Eva B Thorstad, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trialU Jungnelius, U Ringborg, S Aamdal, et al.
British Journal of Cancer|June 27, 2002
Tumour microvessel density as predictor of chemotherapy response in breast cancer patientsO Tynninen, J Sjöström, K von Boguslawski, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II StudyG Saeter, T A Alvegård, O R Monge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancerJ Sjöström, C Blomqvist, P Heikkilä, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2000
Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast GroupJ Sjöström, C Blomqvist, H Mouridsen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancerJ Sjöström, J Collan, K von Boguslawski, et al.
Pageof 12